FEASIBILITY STUDY OF INTRAPERITONEAL (IP) RADIOIMMUNOTHERAPY (RIT) USING IN-111 OC125 MAB IN PATIENTS WITH OVARIAN-CARCINOMA

被引：0
|
作者：
CHATAL, JF
THEDREZ, P
SACCAVINI, JC
NOLIBE, D
GUERREAU, D
PASCAL, G
SIMOEN, JP
PELTIER, P
CHETANNEAU, A
KREMER, M
机构：
[1] INSERM,U211,NANTES,FRANCE
[2] CEA,SACLAY,FRANCE
[3] COMP ORIS IND,SACLAY,FRANCE
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1988年 / 14卷 / 5-6期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 42 条
  • [1] INTRAPERITONEAL RADIOIMMUNOTHERAPY OF REFRACTORY OVARIAN-CARCINOMA UTILIZING IODINE-131-LABELED MONOCLONAL-ANTIBODY OC125
    MUTO, MG
    FINKLER, NJ
    KASSIS, AI
    HOWES, AE
    ANDERSON, LL
    LAU, CC
    ZURAWSKI, VR
    WEADOCK, K
    TUMEH, SS
    LAVIN, P
    KNAPP, RC
    GYNECOLOGIC ONCOLOGY, 1992, 45 (03) : 265 - 272
  • [2] BIODISTRIBUTION OF IN-111 OC 125 MONOCLONAL-ANTIBODY (MAB) IN A NUDE-MOUSE MODEL INTRAPERITONEALLY (IP) GRAFTED WITH A HUMAN OVARIAN-CARCINOMA
    THEDREZ, P
    KREMER, M
    CURTET, C
    SAI, C
    GUERREAU, D
    SACCAVINI, JC
    CHATAL, JF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 240 - 240
  • [3] INTRAPERITONEAL (IP) ADRIAMYCIN (ADR) IN OVARIAN-CARCINOMA (OC)
    OZOLS, RF
    YOUNG, RC
    SPEYER, JL
    WELTZ, M
    COLLINS, JM
    DEDRICK, RL
    MYERS, CE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 425 - 425
  • [4] A PROSPECTIVE EVALUATION OF OC125 AND MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH OVARIAN-CARCINOMA
    PERKINS, AC
    POWELL, MC
    WASTIE, ML
    SCOTT, IV
    HITCHCOCK, A
    WORTHINGTON, BS
    SYMONDS, EM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (4-6): : 311 - 316
  • [5] BIODISTRIBUTION, PHARMACOKINETICS AND IMAGING OF I-131-LABELED OC125 IN PATIENTS WITH OVARIAN-CARCINOMA
    HAISMA, HJ
    MOSELEY, KR
    BATTAILE, A
    ZURAWSKI, VR
    KNAPP, RC
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 519 - 519
  • [6] BIODISTRIBUTION OF IN-111 OC-125 MONOCLONAL-ANTIBODY (MABG) IN NUDE-MICE BEARING INTRAPERITONEAL HUMAN OVARIAN-CARCINOMA
    THEDREZ, P
    KREMER, M
    CURTET, C
    SAI, C
    GUERREAU, D
    SACCAVINI, JC
    CHATAL, JF
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 323 - 323
  • [7] BAYESIAN-ANALYSIS OF INDIUM-111-LABELED OC125 IMMUNOSCINTIGRAPHY IN THE DIAGNOSTIC STRATEGY OF OVARIAN-CARCINOMA RECURRENCE
    PELTIER, P
    DUTIN, JP
    CHATAL, JF
    BOURGUET, P
    LIEHN, JC
    VUILLEZ, JP
    HERRY, JY
    LOBOGUERRERO, A
    DIAGNOSTIC ONCOLOGY, 1993, 3 (01): : 21 - 24
  • [8] INFLUENCE OF MAB F(AB)(2) OC-125 ON THE SURVIVAL RATE OF OVARIAN-CARCINOMA PATIENTS
    NESSELHUT, T
    HYBRIDOMA, 1993, 12 (05): : 567 - 570
  • [9] A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma
    Mahé, MA
    Fumoleau, P
    Fabbro, M
    Guastalla, JP
    Faurous, P
    Chauvot, P
    Chetanoud, L
    Classe, JM
    Rouanet, P
    Chatal, JF
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3249S - 3253S
  • [10] THE IMMUNOREACTIVE FRACTION OF MONOCLONAL-ANTIBODIES AGAINST OVARIAN-CARCINOMA AFTER LABELING WITH IN-111 AND I125
    SHELDON, K
    REILLY, R
    MARKS, A
    HOULE, S
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (07) : 1327 - 1327
12345